Safety and immunogenicity of a new purified vero cell rabies vaccine (PVRV) administered by intramuscular and intradermal routes in healthy volunteers PS Kulkarni, A Sapru, PM D’costa, A Pandit, SN Madhusudana, ... Vaccine 31 (24), 2719-2722, 2013 | 24 | 2013 |
Guide to active vaccine safety surveillance: Report of CIOMS working group on vaccine safety–executive summary U Heininger, K Holm, I Caplanusi, SR Bailey, SA Abdoellah, F Arellano, ... Vaccine 35 (32), 3917-3921, 2017 | 23 | 2017 |
Effectiveness of an Indian-made Attenuated influenza A(H1N1)pdm 2009 vaccine: A case control study PS Kulkarni, S Agarkhedkar, S Lalwani, AR Bavdekar, S Jog, SK Raut, ... Human vaccines & immunotherapeutics 10 (3), 566-571, 2014 | 21 | 2014 |
Effect of prophylactic or therapeutic administration of paracetamol on immune response to DTwP-HepB-Hib combination vaccine in Indian infants A Sil, MD Ravi, BN Patnaik, MS Dhingra, M Dupuy, DJ Gandhi, ... Vaccine 35 (22), 2999-3006, 2017 | 16 | 2017 |
A New Electrochemiluminescence-Based Multiplex Assay for the Assessment of Human Antibody Responses to Bordetella pertussis Vaccines K Varghese, W Bartlett, L Zheng, S Bookhout, D Vincent, J Huleatt, ... Infectious Diseases and Therapy 10 (4), 2539-2561, 2021 | 12 | 2021 |
Safety and immunogenicity of a hexavalent DTwP-IPV-HB-PRP∼ T vaccine versus separate DTwP-HB-PRP∼ T and IPV vaccines in healthy infants in India S Mangarule, S Palkar, M Mitra, MD Ravi, AP Dubey, A Moureau, ... Vaccine: X 10, 100137, 2022 | 7 | 2022 |
A comparative study to evaluate the safety and immunogenicity of two lots of Haemophilus influenzae type-B conjugate vaccine manufactured at different scales S Hirve, A Bavdekar, S Juvekar, D Agarwal, P Barde, S Mangrule, ... Vaccine 29 (33), 5363-5367, 2011 | 6 | 2011 |
Antibody persistence following administration of a hexavalent DTwP-IPV-HB-PRP∼ T vaccine versus separate DTwP-HB-PRP∼ T and IPV vaccines at 12–24 months of age and safety and … S Mangarule, S Palkar, M Mitra, MD Ravi, R Singh, A Moureau, ... Vaccine: X 11, 100190, 2022 | 5 | 2022 |
Lot-to-lot consistency of a hexavalent DTwP-IPV-HB-PRP∼ T vaccine and non-inferiority to separate DTwP-HB-PRP∼ T and IPV antigen-matching vaccines at 6–8, 10–12, and 14–16 … S Mangarule, S Prashanth, A Kawade, MD Ravi, IV Padmavathi, S Palkar, ... Vaccine: X 12, 100216, 2022 | 4 | 2022 |
Vaccine: X S Mangarule, S Prashanth, A Kawade, MD Ravi, IV Padmavathi, S Palkar, ... Vaccine 10 (12), 100216, 2022 | 4* | 2022 |
A New Electrochemiluminescence-Based Multiplex Assay for the Assessment of Human Antibody Responses to Bordetella pertussis Vaccines KVWBL Zheng, S Bookhout, DVJHM Brown, S Mangarule, FNS Hodge | | |